Hence, this study aims to investigate the expression level of AKR1B10 in HCC through bioinformatics analysis techniques and analyze its correlation with clinical characteristics of HCC patients, such as age, gender, tumor size, grading, and survival status, to validate whether the clinical prognostic status indeed correlates with differential expression of AKR1B10. Here, AKR1B10 is linked to neoplasm.